These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28916721)

  • 1. Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy.
    Pereyra AS; Hasek LY; Harris KL; Berman AG; Damen FW; Goergen CJ; Ellis JM
    J Biol Chem; 2017 Nov; 292(45):18443-18456. PubMed ID: 28916721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octanoate is differentially metabolized in liver and muscle and fails to rescue cardiomyopathy in CPT2 deficiency.
    Pereyra AS; Harris KL; Soepriatna AH; Waterbury QA; Bharathi SS; Zhang Y; Fisher-Wellman KH; Goergen CJ; Goetzman ES; Ellis JM
    J Lipid Res; 2021; 62():100069. PubMed ID: 33757734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of mitochondria long-chain fatty acid oxidation impairs skeletal muscle contractility by disrupting myofibril structure and calcium homeostasis.
    Pereyra AS; Fernandez RF; Amorese A; Castro JN; Lin CT; Spangenburg EE; Ellis JM
    Mol Metab; 2024 Nov; 89():102015. PubMed ID: 39182841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy.
    Lewandowski ED; Fischer SK; Fasano M; Banke NH; Walker LA; Huqi A; Wang X; Lopaschuk GD; O'Donnell JM
    Circ Res; 2013 Jan; 112(1):57-65. PubMed ID: 22982985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol-Induced Changes in MicroRNA Expression in Primary Human Fibroblasts Harboring Carnitine-Palmitoyl Transferase-2 Gene Mutation, Leading to Fatty Acid Oxidation Deficiency.
    Aires V; Delmas D; Djouadi F; Bastin J; Cherkaoui-Malki M; Latruffe N
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29271911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of carnitine palymitoyltransferase1b induces cardiac hypertrophy and mortality in mice.
    Haynie KR; Vandanmagsar B; Wicks SE; Zhang J; Mynatt RL
    Diabetes Obes Metab; 2014 Aug; 16(8):757-60. PubMed ID: 24330405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance.
    Lee J; Choi J; Selen Alpergin ES; Zhao L; Hartung T; Scafidi S; Riddle RC; Wolfgang MJ
    Cell Rep; 2017 Jul; 20(3):655-667. PubMed ID: 28723568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.
    Grevengoed TJ; Cooper DE; Young PA; Ellis JM; Coleman RA
    FASEB J; 2015 Nov; 29(11):4641-53. PubMed ID: 26220174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Induced Obesity and Insulin Resistance despite Long-Chain Acylcarnitine Accumulation.
    Pereyra AS; Rajan A; Ferreira CR; Ellis JM
    Cell Rep; 2020 Nov; 33(6):108374. PubMed ID: 33176143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
    Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.
    Hasumi Y; Baba M; Hasumi H; Huang Y; Lang M; Reindorf R; Oh HB; Sciarretta S; Nagashima K; Haines DC; Schneider MD; Adelstein RS; Schmidt LS; Sadoshima J; Marston Linehan W
    Hum Mol Genet; 2014 Nov; 23(21):5706-19. PubMed ID: 24908670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC1 activation is not sufficient to suppress hepatic PPARα signaling or ketogenesis.
    Selen ES; Wolfgang MJ
    J Biol Chem; 2021 Jul; 297(1):100884. PubMed ID: 34146544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy.
    Lee E; Lee HA; Kim M; Do GY; Cho HM; Kim GJ; Jung H; Song JH; Cho JM; Kim I
    Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):226-236. PubMed ID: 30099761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Adipose Fatty Acid Oxidation Does Not Potentiate Obesity at Thermoneutrality.
    Lee J; Choi J; Aja S; Scafidi S; Wolfgang MJ
    Cell Rep; 2016 Feb; 14(6):1308-1316. PubMed ID: 26854223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine palmitoyltransferase deficiencies.
    Bonnefont JP; Demaugre F; Prip-Buus C; Saudubray JM; Brivet M; Abadi N; Thuillier L
    Mol Genet Metab; 1999 Dec; 68(4):424-40. PubMed ID: 10607472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
    Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
    Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.
    Sorokina N; O'Donnell JM; McKinney RD; Pound KM; Woldegiorgis G; LaNoue KF; Ballal K; Taegtmeyer H; Buttrick PM; Lewandowski ED
    Circulation; 2007 Apr; 115(15):2033-41. PubMed ID: 17404155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.